In this study, we assayed and investigated the status of EGFR, KRAS, MET, ALK, ROS1, HER2, RET, BRAF, NRAS, and PIK3CA somatic driver gene alterations derived from 851 Chinese NSCLC patients. Here, KRAS is linked to non-small cell lung carcinoma.